Table 3.
Multivariable analysis on factors associated with preference on type of vaccine (preference versus no preference).
| Variables | Total | Participants Have Preference on Type of Vaccine | Odds Ratio | 95% C.I. | p-Value | ||
|---|---|---|---|---|---|---|---|
| N = 660 | N = 376 | ||||||
| 57.0% | |||||||
| n | n (%) | Lower | Upper | ||||
| Gender | |||||||
| Men | 228 | 132 | (57.9) | ref | |||
| Women | 432 | 244 | (56.5) | 0.68 | 0.47 | 0.97 | 0.038 |
| Age | |||||||
| 18–60 | 358 | 219 | (61.2) | ref | |||
| >61 | 302 | 157 | (52.0) | 0.80 | 0.57 | 1.15 | 0.216 |
| Medical insurance | |||||||
| No | 377 | 201 | (55.3) | ref | |||
| Yes | 283 | 175 | (61.8) | 1.19 | 0.83 | 1.69 | 0.340 |
| Stage of disease | |||||||
| Stage I–III | 276 | 145 | (52.5) | ref | |||
| Stage IV | 384 | 231 | (60.2) | 1.23 | 0.86 | 1.75 | 0.261 |
| Currently on anticancer systemic treatment | |||||||
| No (Radiotherapy/survivors/palliative care) | 204 | 133 | (65.2) | ref | |||
| Yes (On anticancer systemic treatment) | 456 | 243 | (53.3) | 0.66 | 0.45 | 0.98 | 0.038 |
| Worry about getting COVID-19 infection | |||||||
| No | 147 | 76 | (51.7) | ref | |||
| Yes | 513 | 300 | (58.5) | 1.09 | 0.71 | 1.67 | 0.683 |
| Worry more about cancer progression than COVID-19 infection | |||||||
| No | 163 | 96 | (58.9) | ref | |||
| Yes | 497 | 280 | (56.3) | 0.98 | 0.66 | 1.48 | 0.938 |
| Believe that COVID-19 vaccine can prevent COVID-19 infection | |||||||
| No | 173 | 92 | (53.2) | ref | |||
| Yes | 487 | 284 | (58.3) | 1.16 | 0.79 | 1.70 | 0.454 |
| Worry that COVID-19 vaccine will affect cancer treatment | |||||||
| No | 184 | 111 | (60.3) | ref | |||
| Yes | 476 | 265 | (55.7) | 0.87 | 0.57 | 1.32 | 0.508 |
| Worry about short-term side effects of vaccine | |||||||
| No | 96 | 51 | (53.1) | ref | |||
| Yes | 564 | 325 | (57.6) | 1.39 | 0.81 | 2.39 | 0.235 |
| Worry about long-term side effects of vaccine | |||||||
| No | 192 | 107 | (55.7) | ref | |||
| Yes | 468 | 269 | (57.5) | 1.28 | 0.83 | 1.95 | 0.263 |
| CHLT-6 score | 1.23 | 1.07 | 1.41 | 0.004 | |||
| Knowledge about vaccine | 1.38 | 1.21 | 1.57 | 0.001 | |||
| HADS Depression score | |||||||
| Normal/borderline abnormal (score <11) | 458 | 277 | (60.5) | ref | |||
| Abnormal (score ≥11) | 202 | 99 | (49.0) | 0.64 | 0.44 | 0.92 | 0.015 |
| HADS Anxiety score | |||||||
| Normal/borderline abnormal (score <11) | 607 | 346 | (57.0) | ref | |||
| Abnormal (score ≥11) | 53 | 30 | (56.6) | 0.78 | 0.42 | 1.45 | 0.430 |
C.I.: Confidence interval; CHLT-6: Cancer Health Literacy Test-6; HADS: Hospital Anxiety and Depression Score.